Leishmaniasis: new approaches to disease control
Top Cited Papers
- 15 February 2003
- Vol. 326 (7385) , 377-382
- https://doi.org/10.1136/bmj.326.7385.377
Abstract
Leishmaniasis is one of the major infectious diseases affecting the poorest regions of the world, but new developments in diagnosis, treatment, and control offer some fresh hopeKeywords
This publication has 26 references indexed in Scilit:
- Treatment of Indian visceral leishmaniasis with single or daily infusions of low dose liposomal amphotericin B: randomised trial Commentary: cost and resistance remain issuesBMJ, 2001
- Leishmaniasis: Current Status of Vaccine DevelopmentClinical Microbiology Reviews, 2001
- Diagnosing visceral leishmaniasis with the recombinant K39 strip test: experience from the SudanTropical Medicine & International Health, 2001
- Latex agglutination test for the detection of urinary antigens in visceral leishmaniasisActa Tropica, 2001
- Spraying houses in the Peruvian Andes with lambda-cyhalothrin protects residents against cutaneous leishmaniasisTransactions of the Royal Society of Tropical Medicine and Hygiene, 2000
- Autoclaved Leishmania major vaccine for prevention of visceral leishmaniasis: a randomised, double-blind, BCG-controlled trial in SudanThe Lancet, 2000
- Failure of Pentavalent Antimony in Visceral Leishmaniasis in India: Report from the Center of the Indian EpidemicClinical Infectious Diseases, 2000
- A randomized controlled trial of insecticide-treated bednets and chaddars or top sheets, and residual spraying of interior rooms for the prevention of cutaneous leishmaniasis in Kabul, AfghanistanTransactions of the Royal Society of Tropical Medicine and Hygiene, 2000
- Miltefosine, an Oral Agent, for the Treatment of Indian Visceral LeishmaniasisNew England Journal of Medicine, 1999
- Protective Immunity Using Recombinant Human IL-12 and Alum as Adjuvants in a Primate Model of Cutaneous LeishmaniasisThe Journal of Immunology, 1999